Abstract
Purpose
Identify predictors of quality of life (QOL) in patients with any form of cardiac arrhythmia (CA).
Methods
Data from the Medical Panel Expenditure Survey were analyzed from 2004 to 2009. Patients aged ≥18 with any form of CA (identified via ICD-9-CM codes) were included. Primary outcomes included the physical and mental component scores (PCS and MCS) of the Short-Form 12 version 2 (SF-12) and EuroQoL-5D (EQ-5D) utility scores (US version). Patient demographics included insurance status, urban status, geographical region, federal poverty level, education, comorbidities, and disease-related risk factors of CA.
Results
Approximately 5,750,440 individuals had CA. Non-Hispanic Whites had the highest SF-12 MCS (mean 50.9; p < 0.001 across racial groups) and utility scores (mean 0.76; p < 0.001 across racial groups). Patients with both private and public insurance had significantly higher PCS (p = 0.001) and MCS (p < 0.001) in comparison with patients only covered by public insurance. Patients on antiarrhythmic agents had higher SF-12 MCS (51.4 vs. 48.4; p < 0.001) compared to individuals not on antiarrhythmic agents.
Conclusions
Significantly lower QOL existed in specific subpopulations (e.g., patients with only public health insurance, racial/ethnic minorities, and those not exposed to antiarrhythmic agents) within the CA population.
Abbreviations
- CA:
-
Cardiac arrhythmia
- MEPS:
-
Medical Panel Expenditure Survey
- QOL:
-
Quality of life
References
American Heart Association. (2012). http://www.heart.org/HEARTORG/. Accessed February 8, 2012.
The American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2009). Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 119, e21–e181.
Coyne, K. S., Paramore, C., Grandy, S., Mercder, M., Reynolds, M., & Zimetbaum, P. (2006). Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value in Health, 9, 348–356.
Rohrbacker, N. J., Kleinman, N. L., White, S. A., March, J. L., & Reynolds, M. R. (2010). The burden of atrial fibrillation and other cardiac arrhythmias in an employed population: Associated costs, absences, and objective productivity loss. Journal of Occupational and Environmental Medicine, 52, 383–391.
Le Heuzey, J. Y., Paziaud, O., Piot, O., Said, M. A., Copie, X., Lavergne, T., et al. (2004). Cost of care distribution in atrial fibrillation patients: The COCAF study. American Heart Journal, 147, 121–126.
Reynolds, M. R., Essebag, V., Zimetbaum, P., & Cohen, D. J. (2007). Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: The FRACTAL registry. Journal of Cardiovascular Electrophysiology, 18, 628–633.
Dorian, P., Paquette, M., Newman, D., Green, M., Connolly, S. J., Talajic, M., et al. (2002). Quality of life improves with treatment in the Canadian trial of atrial fibrillation. American Heart Journal, 143, 984–990.
Lönnerholm, S., Blomström, P., Nilsson, L., Oxelbark, S., Jideus, L., & Blomström-Lundqvist, C. (2000). Effects of the maze operation on health-related quality of life in patients with atrial fibrillation. Circulation, 101, 2607–2611.
Pappone, C., Rosanio, S., Augello, G., Gallus, G., Vicedomini, G., Mazzone, P., et al. (2003). Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. Journal of the American College of Cardiology, 42, 185–197.
Singh, B. N., Singh, S. N., Reda, D. J., Tang, X. C., Lopez, B., Harris, C. L., et al. (2005). Amiodarone versus sotalol for atrial fibrillation. New England Journal of Medicine, 352, 1861–1872.
MEPS-HC Sample Design and Collection Process. (2012). Agency for Healthcare Research and Quality, Rockville, Md. http://www.meps.ahrq.gov/survey_comp/hc_data_collection.jsp. Accessed April 4, 2012.
Chuang, L. H., & Kind, P. (2009). Converting the SF-12 into the EQ-5D: an empirical comparison of methodologies. Pharmacoeconomics, 27, 491–505.
Chisholm, M. A., Wells, B. G., Schwinghammer, T. L., Malone, P. M., Kolesar, J. M., & Rotschafer, J. C. (Eds.). (2007). Pharmacotherapy principles and practice. New York: McGraw Hill Medical.
D’Hoore, W., Bouckaert, A., & Tilquin, C. (1996). Practical considerations on the use of the Charlson Comorbidity Index with administrative databases. Journal of Clinical Epidemiology, 49, 1429–1433.
Schonlau, M. (2012). Stata software package, hotdeckvar.pkg, for hot deck imputation. 2006. Accessed April 4, 2012. Available from: http://www.schonlau.net/stata/.
Lim, L. Y., & Fisher, J. D. (1999). Use of the 12-item Short-Form (SF-12) Health Survey in Australian heart and stroke population. Quality of Life Research, 8, 1–8.
Dorian, P., & Mangat, I. (2003). Quality of life variables in the selection of rate versus rhythm control in patients with atrial fibrillation: observations from the Canadian trial of atrial fibrillation. Cardiac Electrophysiology Review, 7, 276–279.
Ware, J. E., Snow, K. K., Kosinski, M. A., & Gandek, B. (1993). SF-36 health survey manual and interpretation guide. Boston: The Health Institute, New England Medical Center.
Ware, J. E., Bayliss, M. S., Rogers, W. H., Kosinski, M. A., & Tarlov, A. R. (1996). Differences in 4-year health outcomes for elderly and poor, chronically ill patients treated in HMO and Fee-for-Service Systems: Results from the Medical Outcomes Study. Journal of the American Medical Association, 276, 1039–1047.
Burdine, J. N., Felix, M., Abel, A. L., Wiltraut, C. J., & Musselman, Y. J. (2000). The SF-12 as a population health measure: An exploratory examination of potential for application. Health Services Research, 35, 885–903.
Cheadle, A., Wagner, E., Koepsell, T., Kristal, A., & Patrick, D. (1992). Environmental indicators: A tool for evaluating community-based health promotion programs. American Journal of Preventive Medicine, 8, 345–350.
Marmot, M. G., Bobak, M., Smith. G. D. (1995). Explanations for social inequalities in health. Society and Health. 46–92.
Conflict of interest
These authors have no financial or personal relationships with other people or organizations that could inappropriately influence (bias) this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tang, D.H., Gilligan, A.M. & Romero, K. Association of patient demographics on quality of life in a sample of adult patients with cardiac arrhythmias. Qual Life Res 23, 129–134 (2014). https://doi.org/10.1007/s11136-013-0445-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-013-0445-2